We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERICS, BRANDS UNLIKELY TO CUT NEW ANTICOMPETITIVE DEALS
The item has been added to your shopping cart.
GENERICS, BRANDS UNLIKELY TO CUT NEW ANTICOMPETITIVE DEALS
January 13, 2004
The FTC’s recent ruling that Schering-Plough and several generic firms forged anticompetitive pacts in the 1990s sends a message to drugmakers contemplating similar agreements, though some experts say such deals are no longer in favor in the industry.